Sign up for the QMED & MD+DI Daily newsletter.
MD+DI Managing Editor’s Must-Attend List for BIOMEDevice Silicon Valley
With BIOMEDevice Silicon Valley quickly approaching, this editor highlights some of the sessions she finds particularly exciting.
October 26, 2023
3 Min Read
gorodenkoff / iStock via Getty Images
As the managing editor for MD+DI with an avid interest in the supplier and manufacturing side of medtech, innovation, and the importance of regulatory compliance, here are just a few of the sessions I’m particularly excited about at the Nov. 15-16 BIOMEDevice Silicon Valley conference.
Taking place at the Center Stage on Wednesday, Nov. 15 from 10:30am to 11:15am, Thor Rollins, VP global market segment leader - medical device at Nelson Laboratories, will delve into the evolving concepts within the Committee Draft of ISO 10993-1 and Guidance on Biocompatibility, with a keen focus on their relevance to next-gen design and emerging technologies, and provide insights into their current regulatory acceptance. Furthermore, he will address the latest comments on the draft and resolutions arising from the ISO committee meeting.
Taking place at the Tech Theater on Wednesday Nov. 15 from 11:30am to 12:15pm, Betty Howard, senior radiation sterilization manager at Steris, will compare gamma to X-ray, describe similarities and differences, showcase the benefits of adding X-ray sterilization plans, and discuss considerations in validation and transfers from one radiation technology to another. This presentation will also outline why X-ray is a viable alternative to gamma processing, assuring long-term processing capacity while providing the same level of product assurance.
Taking place at the Center Stage on Wednesday, Nov. 15 from 1pm to 2pm, Surbhi Sarna, author and partner at Y-Combinator, will discuss how she went from patient to an impatient entrepreneur, hiring a best-in-class team, winning two FDA clearances, and completing several clinical trials. The team's work culminated in a blockbuster sale of the company, nVision, to Boston Scientific for $275M.
Taking place at the Center Stage on Wednesday, Nov. 15 from 2:15pm to 3pm, Faycal Benayad-Cherif, global strategic account manager at FOBA, and Tyler Kim, sales manager at FOBA Marking + Engraving, will share the common challenges faced by the medical manufacturing industry, how different technologies and solutions have changed process flow, and cover the lessons learned from the manufacturing of medical implants to reusable instruments in the fields of orthopedics, cardio, spine and dental.
Taking place at the Great America Meeting Room 2 on Thursday, Nov. 16 from 9am to 9:45am, Farid Farahmand, CEO at Tidal Medical Technology, will provide a concise overview of his startup's journey in submitting an FDA application for a Class II device. He will delve into the obstacles The company faced throughout the design and development stages, along with preparations for FDA submission.
Taking place at the Center Stage on Thursday, Nov. 16 from 1pm to 2pm, Pearly Pandya, in-space manufacturing – biomedical at Axiom Space, will highlight biomedical products being developed by Axiom Space that have the potential to change the paradigm of the medtech industry.
About the Author(s)
Managing Editor, MD+DI
Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read